Global Insomnia Market Size, Status and Forecast 2019-2025

Published On: Jun 2019

Format: PDF

Publisher: QY Research

Pages: 92

Report ID: 1611

Insomnia is a sleep disorder where people have trouble sleeping. They may have difficulty falling asleep, or staying asleep as long as desired. Insomnia is typically followed by daytime sleepiness, low energy, irritability, and a depressed mood.
Sleep hygiene and lifestyle changes are typically the first treatment for insomnia. Sleep hygiene includes a consistent bedtime, exposure to sunlight, a quiet and dark room, and regular exercise. Cognitive behavioral therapy may be added to this. While sleeping pills may help, they are associated with injuries, dementia, and addiction.
In 2018, the global Insomnia market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Insomnia status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Insomnia development in United States, Europe and China.

The key players covered in this study
Merck
Eisai
Meda Consumer Healthcare
Takeda Pharmaceuticals
Pfizer
Sanofi
Vanda Pharmaceuticals
Pernix Therapeutics
Purdue Pharmaceuticals

Market segment by Type, the product can be split into
Non-benzodiazepines
Benzodiazepines
Orexin Antagonists
Melatonin Receptor Antagonists
Antihistamines
Melatonin
Valerian Roots
Other Herbal & Dietary Supplements

Market segment by Application, split into
Female
Male
Senior Citizens

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Insomnia status, future forecast, growth opportunity, key market and key players.
To present the Insomnia development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Insomnia are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Insomnia Market Size Growth Rate by Type (2014-2025)
1.4.2 Non-benzodiazepines
1.4.3 Benzodiazepines
1.4.4 Orexin Antagonists
1.4.5 Melatonin Receptor Antagonists
1.4.6 Antihistamines
1.4.7 Melatonin
1.4.8 Valerian Roots
1.4.9 Other Herbal & Dietary Supplements
1.5 Market by Application
1.5.1 Global Insomnia Market Share by Application (2014-2025)
1.5.2 Female
1.5.3 Male
1.5.4 Senior Citizens
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Insomnia Market Size
2.2 Insomnia Growth Trends by Regions
2.2.1 Insomnia Market Size by Regions (2014-2025)
2.2.2 Insomnia Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Insomnia Market Size by Manufacturers
3.1.1 Global Insomnia Revenue by Manufacturers (2014-2019)
3.1.2 Global Insomnia Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Insomnia Market Concentration Ratio (CR5 and HHI)
3.2 Insomnia Key Players Head office and Area Served
3.3 Key Players Insomnia Product/Solution/Service
3.4 Date of Enter into Insomnia Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Insomnia Market Size by Type (2014-2019)
4.2 Global Insomnia Market Size by Application (2014-2019)

5 United States
5.1 United States Insomnia Market Size (2014-2019)
5.2 Insomnia Key Players in United States
5.3 United States Insomnia Market Size by Type
5.4 United States Insomnia Market Size by Application

6 Europe
6.1 Europe Insomnia Market Size (2014-2019)
6.2 Insomnia Key Players in Europe
6.3 Europe Insomnia Market Size by Type
6.4 Europe Insomnia Market Size by Application

7 China
7.1 China Insomnia Market Size (2014-2019)
7.2 Insomnia Key Players in China
7.3 China Insomnia Market Size by Type
7.4 China Insomnia Market Size by Application

8 Japan
8.1 Japan Insomnia Market Size (2014-2019)
8.2 Insomnia Key Players in Japan
8.3 Japan Insomnia Market Size by Type
8.4 Japan Insomnia Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Insomnia Market Size (2014-2019)
9.2 Insomnia Key Players in Southeast Asia
9.3 Southeast Asia Insomnia Market Size by Type
9.4 Southeast Asia Insomnia Market Size by Application

10 India
10.1 India Insomnia Market Size (2014-2019)
10.2 Insomnia Key Players in India
10.3 India Insomnia Market Size by Type
10.4 India Insomnia Market Size by Application

11 Central & South America
11.1 Central & South America Insomnia Market Size (2014-2019)
11.2 Insomnia Key Players in Central & South America
11.3 Central & South America Insomnia Market Size by Type
11.4 Central & South America Insomnia Market Size by Application

12 International Players Profiles
12.1 Merck
12.1.1 Merck Company Details
12.1.2 Company Description and Business Overview
12.1.3 Insomnia Introduction
12.1.4 Merck Revenue in Insomnia Business (2014-2019)
12.1.5 Merck Recent Development
12.2 Eisai
12.2.1 Eisai Company Details
12.2.2 Company Description and Business Overview
12.2.3 Insomnia Introduction
12.2.4 Eisai Revenue in Insomnia Business (2014-2019)
12.2.5 Eisai Recent Development
12.3 Meda Consumer Healthcare
12.3.1 Meda Consumer Healthcare Company Details
12.3.2 Company Description and Business Overview
12.3.3 Insomnia Introduction
12.3.4 Meda Consumer Healthcare Revenue in Insomnia Business (2014-2019)
12.3.5 Meda Consumer Healthcare Recent Development
12.4 Takeda Pharmaceuticals
12.4.1 Takeda Pharmaceuticals Company Details
12.4.2 Company Description and Business Overview
12.4.3 Insomnia Introduction
12.4.4 Takeda Pharmaceuticals Revenue in Insomnia Business (2014-2019)
12.4.5 Takeda Pharmaceuticals Recent Development
12.5 Pfizer
12.5.1 Pfizer Company Details
12.5.2 Company Description and Business Overview
12.5.3 Insomnia Introduction
12.5.4 Pfizer Revenue in Insomnia Business (2014-2019)
12.5.5 Pfizer Recent Development
12.6 Sanofi
12.6.1 Sanofi Company Details
12.6.2 Company Description and Business Overview
12.6.3 Insomnia Introduction
12.6.4 Sanofi Revenue in Insomnia Business (2014-2019)
12.6.5 Sanofi Recent Development
12.7 Vanda Pharmaceuticals
12.7.1 Vanda Pharmaceuticals Company Details
12.7.2 Company Description and Business Overview
12.7.3 Insomnia Introduction
12.7.4 Vanda Pharmaceuticals Revenue in Insomnia Business (2014-2019)
12.7.5 Vanda Pharmaceuticals Recent Development
12.8 Pernix Therapeutics
12.8.1 Pernix Therapeutics Company Details
12.8.2 Company Description and Business Overview
12.8.3 Insomnia Introduction
12.8.4 Pernix Therapeutics Revenue in Insomnia Business (2014-2019)
12.8.5 Pernix Therapeutics Recent Development
12.9 Purdue Pharmaceuticals
12.9.1 Purdue Pharmaceuticals Company Details
12.9.2 Company Description and Business Overview
12.9.3 Insomnia Introduction
12.9.4 Purdue Pharmaceuticals Revenue in Insomnia Business (2014-2019)
12.9.5 Purdue Pharmaceuticals Recent Development

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details